{"entity":{"type":"insider","cik":"0001445826","url":"/insider/0001445826","json_url":"/insider/0001445826.json","name":"Epstein David R","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":57,"n_filings":34,"first":"2019-06-27","last":"2026-08-05","span_basis":"filed_date"},"name_variants":[{"name":"Epstein David R","source":"filing","n_filings":34,"first_seen":"2019-06-27","last_seen":"2026-08-05"}],"transactions":[{"id":6092631,"accession":"0001445826-26-000010","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001445826-26-000010","line_url":"/filing/0001445826-26-000010#line-1","is_derivative":false,"issuer_cik":"0001445826","issuer_name":"Tempus AI, Inc.","issuer_ticker":"TEM","issuer_name_source":null,"issuer_url":"/issuer/0001445826","owner_cik":"0001445826","owner_name":"Epstein David R","owner_display_name":"Epstein David R","owner_url":"/insider/0001445826","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":370.0,"shares_display":"370","price_per_share":43.4,"price_display":"43.40","price_state":"stated","total_value":16058.0,"total_display":"16,058.00","total_whole":"16,058","shares_owned_after":31094.0,"shares_owned_after_display":"31,094","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-03","filed_date":"2026-08-05","scope":"insider"},{"id":6129505,"accession":"0001445826-26-000008","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001445826-26-000008","line_url":"/filing/0001445826-26-000008#line-1","is_derivative":false,"issuer_cik":"0001445826","issuer_name":"Tempus AI, Inc.","issuer_ticker":"TEM","issuer_name_source":null,"issuer_url":"/issuer/0001445826","owner_cik":"0001445826","owner_name":"Epstein David R","owner_display_name":"Epstein David R","owner_url":"/insider/0001445826","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":250.0,"shares_display":"250","price_per_share":49.4,"price_display":"49.40","price_state":"stated","total_value":12350.0,"total_display":"12,350.00","total_whole":"12,350","shares_owned_after":31464.0,"shares_owned_after_display":"31,464","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-01","filed_date":"2026-06-03","scope":"insider"},{"id":5823740,"accession":"0001445826-26-000004","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001445826-26-000004","line_url":"/filing/0001445826-26-000004#line-1","is_derivative":false,"issuer_cik":"0001445826","issuer_name":"Tempus AI, Inc.","issuer_ticker":"TEM","issuer_name_source":null,"issuer_url":"/issuer/0001445826","owner_cik":"0001445826","owner_name":"Epstein David R","owner_display_name":"Epstein David R","owner_url":"/insider/0001445826","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":250.0,"shares_display":"250","price_per_share":50.69,"price_display":"50.69","price_state":"stated","total_value":12672.5,"total_display":"12,672.50","total_whole":"12,673","shares_owned_after":25801.0,"shares_owned_after_display":"25,801","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-02","filed_date":"2026-03-04","scope":"insider"},{"id":5755637,"accession":"0001445826-26-000002","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001445826-26-000002","line_url":"/filing/0001445826-26-000002#line-1","is_derivative":false,"issuer_cik":"0001445826","issuer_name":"Tempus AI, Inc.","issuer_ticker":"TEM","issuer_name_source":null,"issuer_url":"/issuer/0001445826","owner_cik":"0001445826","owner_name":"Epstein David R","owner_display_name":"Epstein David R","owner_url":"/insider/0001445826","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":370.0,"shares_display":"370","price_per_share":59.41,"price_display":"59.41","price_state":"stated","total_value":21981.7,"total_display":"21,981.70","total_whole":"21,982","shares_owned_after":26051.0,"shares_owned_after_display":"26,051","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-02","filed_date":"2026-02-04","scope":"insider"},{"id":4565917,"accession":"0001445826-25-000006","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001445826-25-000006","line_url":"/filing/0001445826-25-000006#line-1","is_derivative":false,"issuer_cik":"0001445826","issuer_name":"Tempus AI, Inc.","issuer_ticker":"TEM","issuer_name_source":null,"issuer_url":"/issuer/0001445826","owner_cik":"0001445826","owner_name":"Epstein David R","owner_display_name":"Epstein David R","owner_url":"/insider/0001445826","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A Comnmon Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":250.0,"shares_display":"250","price_per_share":75.55,"price_display":"75.55","price_state":"stated","total_value":18887.5,"total_display":"18,887.50","total_whole":"18,888","shares_owned_after":26421.0,"shares_owned_after_display":"26,421","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-01","filed_date":"2025-12-03","scope":"insider"},{"id":4056035,"accession":"0001445826-25-000004","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001445826-25-000004","line_url":"/filing/0001445826-25-000004#line-1","is_derivative":false,"issuer_cik":"0001445826","issuer_name":"Tempus AI, Inc.","issuer_ticker":"TEM","issuer_name_source":null,"issuer_url":"/issuer/0001445826","owner_cik":"0001445826","owner_name":"Epstein David R","owner_display_name":"Epstein David R","owner_url":"/insider/0001445826","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":370.0,"shares_display":"370","price_per_share":90.0,"price_display":"90.00","price_state":"stated","total_value":33300.0,"total_display":"33,300.00","total_whole":"33,300","shares_owned_after":26671.0,"shares_owned_after_display":"26,671","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-03","filed_date":"2025-11-05","scope":"insider"},{"id":5194441,"accession":"0001415889-25-023653","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-25-023653","line_url":"/filing/0001415889-25-023653#line-1","is_derivative":false,"issuer_cik":"0001445826","issuer_name":"Tempus AI, Inc.","issuer_ticker":"TEM","issuer_name_source":null,"issuer_url":"/issuer/0001445826","owner_cik":"0001445826","owner_name":"Epstein David R","owner_display_name":"Epstein David R","owner_url":"/insider/0001445826","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A Comnmon Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":250.0,"shares_display":"250","price_per_share":73.64,"price_display":"73.64","price_state":"stated","total_value":18410.0,"total_display":"18,410.00","total_whole":"18,410","shares_owned_after":27041.0,"shares_owned_after_display":"27,041","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-02","filed_date":"2025-09-04","scope":"insider"},{"id":4358796,"accession":"0001415889-25-021029","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-25-021029","line_url":"/filing/0001415889-25-021029#line-1","is_derivative":false,"issuer_cik":"0001445826","issuer_name":"Tempus AI, Inc.","issuer_ticker":"TEM","issuer_name_source":null,"issuer_url":"/issuer/0001445826","owner_cik":"0001445826","owner_name":"Epstein David R","owner_display_name":"Epstein David R","owner_url":"/insider/0001445826","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A Comnmon Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":370.0,"shares_display":"370","price_per_share":55.16,"price_display":"55.16","price_state":"stated","total_value":20409.2,"total_display":"20,409.20","total_whole":"20,409","shares_owned_after":27291.0,"shares_owned_after_display":"27,291","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-01","filed_date":"2025-08-05","scope":"insider"},{"id":4707963,"accession":"0001415889-25-015575","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-25-015575","line_url":"/filing/0001415889-25-015575#line-1","is_derivative":false,"issuer_cik":"0001445826","issuer_name":"Tempus AI, Inc.","issuer_ticker":"TEM","issuer_name_source":null,"issuer_url":"/issuer/0001445826","owner_cik":"0001445826","owner_name":"Epstein David R","owner_display_name":"Epstein David R","owner_url":"/insider/0001445826","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A Comnmon Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":250.0,"shares_display":"250","price_per_share":55.2,"price_display":"55.20","price_state":"stated","total_value":13800.0,"total_display":"13,800.00","total_whole":"13,800","shares_owned_after":27661.0,"shares_owned_after_display":"27,661","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-06-02","filed_date":"2025-06-04","scope":"insider"},{"id":4641073,"accession":"0001415889-25-011951","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-25-011951","line_url":"/filing/0001415889-25-011951#line-1","is_derivative":false,"issuer_cik":"0001445826","issuer_name":"Tempus AI, Inc.","issuer_ticker":"TEM","issuer_name_source":null,"issuer_url":"/issuer/0001445826","owner_cik":"0001445826","owner_name":"Epstein David R","owner_display_name":"Epstein David R","owner_url":"/insider/0001445826","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":370.0,"shares_display":"370","price_per_share":53.5,"price_display":"53.50","price_state":"stated","total_value":19795.0,"total_display":"19,795.00","total_whole":"19,795","shares_owned_after":25914.0,"shares_owned_after_display":"25,914","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-05-01","filed_date":"2025-05-05","scope":"insider"},{"id":4433406,"accession":"0001415889-25-008656","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-25-008656","line_url":"/filing/0001415889-25-008656#line-1","is_derivative":false,"issuer_cik":"0001445826","issuer_name":"Tempus AI, Inc.","issuer_ticker":"TEM","issuer_name_source":null,"issuer_url":"/issuer/0001445826","owner_cik":"0001445826","owner_name":"Epstein David R","owner_display_name":"Epstein David R","owner_url":"/insider/0001445826","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":990.0,"shares_display":"990","price_per_share":46.83,"price_display":"46.83","price_state":"stated","total_value":46361.7,"total_display":"46,361.70","total_whole":"46,362","shares_owned_after":26284.0,"shares_owned_after_display":"26,284","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-17","filed_date":"2025-03-19","scope":"insider"},{"id":4108270,"accession":"0001415889-25-006936","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-25-006936","line_url":"/filing/0001415889-25-006936#line-1","is_derivative":false,"issuer_cik":"0001445826","issuer_name":"Tempus AI, Inc.","issuer_ticker":"TEM","issuer_name_source":null,"issuer_url":"/issuer/0001445826","owner_cik":"0001445826","owner_name":"Epstein David R","owner_display_name":"Epstein David R","owner_url":"/insider/0001445826","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":250.0,"shares_display":"250","price_per_share":57.52,"price_display":"57.52","price_state":"stated","total_value":14380.0,"total_display":"14,380.00","total_whole":"14,380","shares_owned_after":27274.0,"shares_owned_after_display":"27,274","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-03","filed_date":"2025-03-05","scope":"insider"},{"id":4050531,"accession":"0001415889-25-003151","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-25-003151","line_url":"/filing/0001415889-25-003151#line-1","is_derivative":false,"issuer_cik":"0001445826","issuer_name":"Tempus AI, Inc.","issuer_ticker":"TEM","issuer_name_source":null,"issuer_url":"/issuer/0001445826","owner_cik":"0001445826","owner_name":"Epstein David R","owner_display_name":"Epstein David R","owner_url":"/insider/0001445826","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":370.0,"shares_display":"370","price_per_share":53.31,"price_display":"53.31","price_state":"stated","total_value":19724.7,"total_display":"19,724.70","total_whole":"19,725","shares_owned_after":27524.0,"shares_owned_after_display":"27,524","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-03","filed_date":"2025-02-05","scope":"insider"},{"id":2157306,"accession":"0001415889-24-029368","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-029368","line_url":"/filing/0001415889-24-029368#line-1","is_derivative":false,"issuer_cik":"0001445826","issuer_name":"Tempus AI, Inc.","issuer_ticker":"TEM","issuer_name_source":null,"issuer_url":"/issuer/0001445826","owner_cik":"0001445826","owner_name":"Epstein David R","owner_display_name":"Epstein David R","owner_url":"/insider/0001445826","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":620.0,"shares_display":"620","price_per_share":41.81,"price_display":"41.81","price_state":"stated","total_value":25922.2,"total_display":"25,922.20","total_whole":"25,922","shares_owned_after":27894.0,"shares_owned_after_display":"27,894","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-11","filed_date":"2024-12-13","scope":"insider"},{"id":7916169,"accession":"0001203311-23-000123","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001203311-23-000123","line_url":"/filing/0001203311-23-000123#line-1","is_derivative":false,"issuer_cik":"0001060736","issuer_name":"Seagen Inc.","issuer_ticker":"SGEN","issuer_name_source":null,"issuer_url":"/issuer/0001060736","owner_cik":"0001445826","owner_name":"Epstein David R","owner_display_name":"Epstein David R","owner_url":"/insider/0001445826","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10620.0,"shares_display":"10,620","price_per_share":213.01,"price_display":"213.01","price_state":"stated","total_value":2262166.2,"total_display":"2,262,166.20","total_whole":"2,262,166","shares_owned_after":136598.0,"shares_owned_after_display":"136,598","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-10","filed_date":"2023-11-13","scope":"insider"},{"id":6104713,"accession":"0001694665-22-000083","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001694665-22-000083","line_url":"/filing/0001694665-22-000083#line-1","is_derivative":false,"issuer_cik":"0001445826","issuer_name":"Evelo Biosciences, Inc.","issuer_ticker":"EVLO","issuer_name_source":null,"issuer_url":"/issuer/0001445826","owner_cik":"0001445826","owner_name":"Epstein David R","owner_display_name":"Epstein David R","owner_url":"/insider/0001445826","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":17123.0,"shares_display":"17,123","price_per_share":1.46,"price_display":"1.46","price_state":"stated","total_value":24999.58,"total_display":"24,999.58","total_whole":"25,000","shares_owned_after":84080.0,"shares_owned_after_display":"84,080","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-27","filed_date":"2022-05-31","scope":"insider"},{"id":6343757,"accession":"0001179110-22-002716","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-22-002716","line_url":"/filing/0001179110-22-002716#line-1","is_derivative":false,"issuer_cik":"0001445826","issuer_name":"Rubius Therapeutics, Inc.","issuer_ticker":"RUBY","issuer_name_source":null,"issuer_url":"/issuer/0001445826","owner_cik":"0001445826","owner_name":"Epstein David R","owner_display_name":"Epstein David R","owner_url":"/insider/0001445826","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":30000.0,"shares_display":"30,000","price_per_share":1.4443,"price_display":"1.44","price_state":"stated","total_value":43329.0,"total_display":"43,329.00","total_whole":"43,329","shares_owned_after":4720012.0,"shares_owned_after_display":"4,720,012","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-04-21","filed_date":"2022-04-22","scope":"insider"},{"id":6745184,"accession":"0001104659-22-035343","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-22-035343","line_url":"/filing/0001104659-22-035343#line-1","is_derivative":false,"issuer_cik":"0001445826","issuer_name":"Axcella Health Inc.","issuer_ticker":"AXLA","issuer_name_source":null,"issuer_url":"/issuer/0001445826","owner_cik":"0001445826","owner_name":"Epstein David R","owner_display_name":"Epstein David R","owner_url":"/insider/0001445826","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":26178.0,"shares_display":"26,178","price_per_share":1.91,"price_display":"1.91","price_state":"stated","total_value":49999.98,"total_display":"49,999.98","total_whole":"50,000","shares_owned_after":161162.0,"shares_owned_after_display":"161,162","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-16","filed_date":"2022-03-18","scope":"insider"},{"id":4295241,"accession":"0001179110-21-001776","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-21-001776","line_url":"/filing/0001179110-21-001776#line-1","is_derivative":false,"issuer_cik":"0001445826","issuer_name":"Rubius Therapeutics, Inc.","issuer_ticker":"RUBY","issuer_name_source":null,"issuer_url":"/issuer/0001445826","owner_cik":"0001445826","owner_name":"Epstein David R","owner_display_name":"Epstein David R","owner_url":"/insider/0001445826","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":26704.0,"shares_display":"26,704","price_per_share":14.9251,"price_display":"14.93","price_state":"stated","total_value":398559.8704,"total_display":"398,559.87","total_whole":"398,560","shares_owned_after":4690012.0,"shares_owned_after_display":"4,690,012","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-11","filed_date":"2021-02-16","scope":"insider"},{"id":4687450,"accession":"0001179110-21-001566","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001179110-21-001566","line_url":"/filing/0001179110-21-001566#line-3","is_derivative":false,"issuer_cik":"0001445826","issuer_name":"Rubius Therapeutics, Inc.","issuer_ticker":"RUBY","issuer_name_source":null,"issuer_url":"/issuer/0001445826","owner_cik":"0001445826","owner_name":"Epstein David R","owner_display_name":"Epstein David R","owner_url":"/insider/0001445826","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7404.0,"shares_display":"7,404","price_per_share":14.7927,"price_display":"14.79","price_state":"stated","total_value":109525.1508,"total_display":"109,525.15","total_whole":"109,525","shares_owned_after":4716716.0,"shares_owned_after_display":"4,716,716","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-10","filed_date":"2021-02-10","scope":"insider"},{"id":4687444,"accession":"0001179110-21-001566","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-21-001566","line_url":"/filing/0001179110-21-001566#line-2","is_derivative":false,"issuer_cik":"0001445826","issuer_name":"Rubius Therapeutics, Inc.","issuer_ticker":"RUBY","issuer_name_source":null,"issuer_url":"/issuer/0001445826","owner_cik":"0001445826","owner_name":"Epstein David R","owner_display_name":"Epstein David R","owner_url":"/insider/0001445826","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2100.0,"shares_display":"2,100","price_per_share":14.8314,"price_display":"14.83","price_state":"stated","total_value":31145.94,"total_display":"31,145.94","total_whole":"31,146","shares_owned_after":4724120.0,"shares_owned_after_display":"4,724,120","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-09","filed_date":"2021-02-10","scope":"insider"},{"id":4687435,"accession":"0001179110-21-001566","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-21-001566","line_url":"/filing/0001179110-21-001566#line-1","is_derivative":false,"issuer_cik":"0001445826","issuer_name":"Rubius Therapeutics, Inc.","issuer_ticker":"RUBY","issuer_name_source":null,"issuer_url":"/issuer/0001445826","owner_cik":"0001445826","owner_name":"Epstein David R","owner_display_name":"Epstein David R","owner_url":"/insider/0001445826","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":89233.0,"shares_display":"89,233","price_per_share":14.8837,"price_display":"14.88","price_state":"stated","total_value":1328117.2021,"total_display":"1,328,117.20","total_whole":"1,328,117","shares_owned_after":4726220.0,"shares_owned_after_display":"4,726,220","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-08","filed_date":"2021-02-10","scope":"insider"},{"id":3267777,"accession":"0001694665-20-000099","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001694665-20-000099","line_url":"/filing/0001694665-20-000099","is_derivative":false,"issuer_cik":"0001445826","issuer_name":"Evelo Biosciences, Inc.","issuer_ticker":"EVLO","issuer_name_source":null,"issuer_url":"/issuer/0001445826","owner_cik":"0001445826","owner_name":"Epstein David R","owner_display_name":"Epstein David R","owner_url":"/insider/0001445826","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7700.0,"shares_display":"7,700","price_per_share":6.657246753246754,"price_display":"6.66","price_state":"stated","total_value":51260.8,"total_display":"51,260.80","total_whole":"51,261","shares_owned_after":15200.0,"shares_owned_after_display":"15,200","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-11","filed_date":"2020-12-14","scope":"insider","n_lines":7},{"id":2441603,"accession":"0001694665-20-000081","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001694665-20-000081","line_url":"/filing/0001694665-20-000081","is_derivative":false,"issuer_cik":"0001445826","issuer_name":"Evelo Biosciences, Inc.","issuer_ticker":"EVLO","issuer_name_source":null,"issuer_url":"/issuer/0001445826","owner_cik":"0001445826","owner_name":"Epstein David R","owner_display_name":"Epstein David R","owner_url":"/insider/0001445826","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5752.0,"shares_display":"5,752","price_per_share":4.486077885952712,"price_display":"4.49","price_state":"stated","total_value":25803.92,"total_display":"25,803.92","total_whole":"25,804","shares_owned_after":7000.0,"shares_owned_after_display":"7,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-31","filed_date":"2020-09-01","scope":"insider","n_lines":4},{"id":2441589,"accession":"0001694665-20-000081","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001694665-20-000081","line_url":"/filing/0001694665-20-000081","is_derivative":false,"issuer_cik":"0001445826","issuer_name":"Evelo Biosciences, Inc.","issuer_ticker":"EVLO","issuer_name_source":null,"issuer_url":"/issuer/0001445826","owner_cik":"0001445826","owner_name":"Epstein David R","owner_display_name":"Epstein David R","owner_url":"/insider/0001445826","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4248.0,"shares_display":"4,248","price_per_share":4.385875706214689,"price_display":"4.39","price_state":"stated","total_value":18631.2,"total_display":"18,631.20","total_whole":"18,631","shares_owned_after":4248.0,"shares_owned_after_display":"4,248","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-28","filed_date":"2020-09-01","scope":"insider","n_lines":2},{"id":3042863,"accession":"0001104659-20-064239","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-20-064239","line_url":"/filing/0001104659-20-064239#line-1","is_derivative":false,"issuer_cik":"0001445826","issuer_name":"Axcella Health Inc.","issuer_ticker":"AXLA","issuer_name_source":null,"issuer_url":"/issuer/0001445826","owner_cik":"0001445826","owner_name":"Epstein David R","owner_display_name":"Epstein David R","owner_url":"/insider/0001445826","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":50000.0,"shares_display":"50,000","price_per_share":4.75,"price_display":"4.75","price_state":"stated","total_value":237500.0,"total_display":"237,500.00","total_whole":"237,500","shares_owned_after":118103.0,"shares_owned_after_display":"118,103","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-18","filed_date":"2020-05-20","scope":"insider"},{"id":2606263,"accession":"0001104659-20-036113","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-20-036113","line_url":"/filing/0001104659-20-036113#line-1","is_derivative":false,"issuer_cik":"0001445826","issuer_name":"Rubius Therapeutics, Inc.","issuer_ticker":"RUBY","issuer_name_source":null,"issuer_url":"/issuer/0001445826","owner_cik":"0001445826","owner_name":"Epstein David R","owner_display_name":"Epstein David R","owner_url":"/insider/0001445826","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":3.76,"price_display":"3.76","price_state":"stated","total_value":18800.0,"total_display":"18,800.00","total_whole":"18,800","shares_owned_after":4815453.0,"shares_owned_after_display":"4,815,453","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-17","filed_date":"2020-03-19","scope":"insider"},{"id":2743025,"accession":"0001104659-20-034857","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-20-034857","line_url":"/filing/0001104659-20-034857","is_derivative":false,"issuer_cik":"0001445826","issuer_name":"Rubius Therapeutics, Inc.","issuer_ticker":"RUBY","issuer_name_source":null,"issuer_url":"/issuer/0001445826","owner_cik":"0001445826","owner_name":"Epstein David R","owner_display_name":"Epstein David R","owner_url":"/insider/0001445826","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":3.91,"price_display":"3.91","price_state":"stated","total_value":39100.0,"total_display":"39,100.00","total_whole":"39,100","shares_owned_after":4810453.0,"shares_owned_after_display":"4,810,453","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-13","filed_date":"2020-03-17","scope":"insider","n_lines":2},{"id":3328373,"accession":"0001104659-20-028089","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-20-028089","line_url":"/filing/0001104659-20-028089#line-2","is_derivative":false,"issuer_cik":"0001445826","issuer_name":"Axcella Health Inc.","issuer_ticker":"AXLA","issuer_name_source":null,"issuer_url":"/issuer/0001445826","owner_cik":"0001445826","owner_name":"Epstein David R","owner_display_name":"Epstein David R","owner_url":"/insider/0001445826","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2005.0,"shares_display":"2,005","price_per_share":3.75,"price_display":"3.75","price_state":"stated","total_value":7518.75,"total_display":"7,518.75","total_whole":"7,519","shares_owned_after":68103.0,"shares_owned_after_display":"68,103","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-28","filed_date":"2020-03-02","scope":"insider"},{"id":3328371,"accession":"0001104659-20-028089","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-20-028089","line_url":"/filing/0001104659-20-028089#line-1","is_derivative":false,"issuer_cik":"0001445826","issuer_name":"Axcella Health Inc.","issuer_ticker":"AXLA","issuer_name_source":null,"issuer_url":"/issuer/0001445826","owner_cik":"0001445826","owner_name":"Epstein David R","owner_display_name":"Epstein David R","owner_url":"/insider/0001445826","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":12800.0,"shares_display":"12,800","price_per_share":3.65,"price_display":"3.65","price_state":"stated","total_value":46720.0,"total_display":"46,720.00","total_whole":"46,720","shares_owned_after":66098.0,"shares_owned_after_display":"66,098","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-27","filed_date":"2020-03-02","scope":"insider"},{"id":8247387,"accession":"0001633070-19-000027","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001633070-19-000027","line_url":"/filing/0001633070-19-000027#line-2","is_derivative":false,"issuer_cik":"0001445826","issuer_name":"Axcella Health Inc.","issuer_ticker":"AXLA","issuer_name_source":null,"issuer_url":"/issuer/0001445826","owner_cik":"0001445826","owner_name":"Epstein David R","owner_display_name":"Epstein David R","owner_url":"/insider/0001445826","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1005.0,"shares_display":"1,005","price_per_share":3.91,"price_display":"3.91","price_state":"stated","total_value":3929.55,"total_display":"3,929.55","total_whole":"3,930","shares_owned_after":53298.0,"shares_owned_after_display":"53,298","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-11-27","filed_date":"2019-12-03","scope":"insider"},{"id":8116158,"accession":"0001104659-19-069117","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-19-069117","line_url":"/filing/0001104659-19-069117#line-2","is_derivative":false,"issuer_cik":"0001445826","issuer_name":"Axcella Health Inc.","issuer_ticker":"AXLA","issuer_name_source":null,"issuer_url":"/issuer/0001445826","owner_cik":"0001445826","owner_name":"Epstein David R","owner_display_name":"Epstein David R","owner_url":"/insider/0001445826","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1005.0,"shares_display":"1,005","price_per_share":3.91,"price_display":"3.91","price_state":"stated","total_value":3929.55,"total_display":"3,929.55","total_whole":"3,930","shares_owned_after":53298.0,"shares_owned_after_display":"53,298","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-11-27","filed_date":"2019-12-02","scope":"insider"},{"id":8247384,"accession":"0001633070-19-000027","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001633070-19-000027","line_url":"/filing/0001633070-19-000027#line-1","is_derivative":false,"issuer_cik":"0001445826","issuer_name":"Axcella Health Inc.","issuer_ticker":"AXLA","issuer_name_source":null,"issuer_url":"/issuer/0001445826","owner_cik":"0001445826","owner_name":"Epstein David R","owner_display_name":"Epstein David R","owner_url":"/insider/0001445826","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":14000.0,"shares_display":"14,000","price_per_share":3.55,"price_display":"3.55","price_state":"stated","total_value":49700.0,"total_display":"49,700.00","total_whole":"49,700","shares_owned_after":52293.0,"shares_owned_after_display":"52,293","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-11-26","filed_date":"2019-12-03","scope":"insider"},{"id":8116156,"accession":"0001104659-19-069117","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-19-069117","line_url":"/filing/0001104659-19-069117#line-1","is_derivative":false,"issuer_cik":"0001445826","issuer_name":"Axcella Health Inc.","issuer_ticker":"AXLA","issuer_name_source":null,"issuer_url":"/issuer/0001445826","owner_cik":"0001445826","owner_name":"Epstein David R","owner_display_name":"Epstein David R","owner_url":"/insider/0001445826","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":14000.0,"shares_display":"14,000","price_per_share":3.55,"price_display":"3.55","price_state":"stated","total_value":49700.0,"total_display":"49,700.00","total_whole":"49,700","shares_owned_after":52293.0,"shares_owned_after_display":"52,293","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-11-26","filed_date":"2019-12-02","scope":"insider"},{"id":8115963,"accession":"0001104659-19-043970","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-19-043970","line_url":"/filing/0001104659-19-043970#line-2","is_derivative":false,"issuer_cik":"0001445826","issuer_name":"Axcella Health Inc.","issuer_ticker":"AXLA","issuer_name_source":null,"issuer_url":"/issuer/0001445826","owner_cik":"0001445826","owner_name":"Epstein David R","owner_display_name":"Epstein David R","owner_url":"/insider/0001445826","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2849.0,"shares_display":"2,849","price_per_share":7.04,"price_display":"7.04","price_state":"stated","total_value":20056.96,"total_display":"20,056.96","total_whole":"20,057","shares_owned_after":38293.0,"shares_owned_after_display":"38,293","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-02","filed_date":"2019-08-05","scope":"insider"},{"id":8115962,"accession":"0001104659-19-043970","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-19-043970","line_url":"/filing/0001104659-19-043970#line-1","is_derivative":false,"issuer_cik":"0001445826","issuer_name":"Axcella Health Inc.","issuer_ticker":"AXLA","issuer_name_source":null,"issuer_url":"/issuer/0001445826","owner_cik":"0001445826","owner_name":"Epstein David R","owner_display_name":"Epstein David R","owner_url":"/insider/0001445826","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4092.0,"shares_display":"4,092","price_per_share":6.98,"price_display":"6.98","price_state":"stated","total_value":28562.16,"total_display":"28,562.16","total_whole":"28,562","shares_owned_after":35444.0,"shares_owned_after_display":"35,444","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-01","filed_date":"2019-08-05","scope":"insider"},{"id":8379885,"accession":"0001104659-19-041034","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-19-041034","line_url":"/filing/0001104659-19-041034#line-1","is_derivative":false,"issuer_cik":"0001445826","issuer_name":"Axcella Health Inc.","issuer_ticker":"AXLA","issuer_name_source":null,"issuer_url":"/issuer/0001445826","owner_cik":"0001445826","owner_name":"Epstein David R","owner_display_name":"Epstein David R","owner_url":"/insider/0001445826","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":7.55,"price_display":"7.55","price_state":"stated","total_value":7550.0,"total_display":"7,550.00","total_whole":"7,550","shares_owned_after":31352.0,"shares_owned_after_display":"31,352","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-07-17","filed_date":"2019-07-18","scope":"insider"},{"id":8310242,"accession":"0001104659-19-039864","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-19-039864","line_url":"/filing/0001104659-19-039864#line-3","is_derivative":false,"issuer_cik":"0001445826","issuer_name":"Axcella Health Inc.","issuer_ticker":"AXLA","issuer_name_source":null,"issuer_url":"/issuer/0001445826","owner_cik":"0001445826","owner_name":"Epstein David R","owner_display_name":"Epstein David R","owner_url":"/insider/0001445826","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1322.0,"shares_display":"1,322","price_per_share":8.07,"price_display":"8.07","price_state":"stated","total_value":10668.54,"total_display":"10,668.54","total_whole":"10,669","shares_owned_after":30352.0,"shares_owned_after_display":"30,352","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-07-10","filed_date":"2019-07-10","scope":"insider"},{"id":8310240,"accession":"0001104659-19-039864","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-19-039864","line_url":"/filing/0001104659-19-039864#line-2","is_derivative":false,"issuer_cik":"0001445826","issuer_name":"Axcella Health Inc.","issuer_ticker":"AXLA","issuer_name_source":null,"issuer_url":"/issuer/0001445826","owner_cik":"0001445826","owner_name":"Epstein David R","owner_display_name":"Epstein David R","owner_url":"/insider/0001445826","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4200.0,"shares_display":"4,200","price_per_share":8.24,"price_display":"8.24","price_state":"stated","total_value":34608.0,"total_display":"34,608.00","total_whole":"34,608","shares_owned_after":29030.0,"shares_owned_after_display":"29,030","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-07-09","filed_date":"2019-07-10","scope":"insider"}],"collapsed":true,"next_cursor":"2019-07-09|8310240","ledger_fault":false,"count":{"value":57,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":38,"open_market":true},{"code":"S","label":"Open-market sale","n":19,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":57},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001717115","name":"Tempus AI, Inc.","url":"/issuer/0001717115","role":"Director","n_filings":14,"first_seen":"2024-12-13","last_seen":"2026-08-05"},{"type":"issuer","type_label":"ISSUER","cik":"0001060736","name":"Seagen Inc.","url":"/issuer/0001060736","role":"Director, Officer (CEO)","n_filings":1,"first_seen":"2023-11-13","last_seen":"2023-11-13"},{"type":"issuer","type_label":"ISSUER","cik":"0001694665","name":"Evelo Biosciences, Inc.","url":"/issuer/0001694665","role":"Director","n_filings":3,"first_seen":"2020-09-01","last_seen":"2022-05-31"},{"type":"issuer","type_label":"ISSUER","cik":"0001709401","name":"Rubius Therapeutics, Inc.","url":"/issuer/0001709401","role":"Director","n_filings":5,"first_seen":"2020-03-17","last_seen":"2022-04-22"},{"type":"issuer","type_label":"ISSUER","cik":"0001633070","name":"Axcella Health Inc.","url":"/issuer/0001633070","role":"Director","n_filings":11,"first_seen":"2019-06-27","last_seen":"2022-03-18"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001445826","retrieved_at":"2026-08-23T19:16:48+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}